From operating puny units in the 1990s, leading Indian pharmaceutical companies have seen a dream run. Through challenges, there came opportunities. Industry leaders like Yusuf Hamied, Dilip Shanghvi, and Pankaj Patel did what they could do best with limited resources.
But will that be good enough to grow from here on? Can generic drugs alone fuel growth? Can India ever develop a blockbuster drug — something that has been elusive for so long? That’s where young leaders come in — unlearning and learning as they think differently on how to do things. Let’s try and understand how young minds are working and challenging the status quo.

PrimeTalk: Redefining Indian pharma: through the lens of young leaders | ET Prime.